Edinburgh Orthopaedics, Royal Infirmary of Edinburgh, NHS Lothian, Edinburgh, UK.
Institute of Biomedical and Environmental Health Research, University of the West of Scotland, Paisley, UK.
Bone Joint J. 2022 Mar;104-B(3):321-330. doi: 10.1302/0301-620X.104B3.BJJ-2021-1052.R1.
Sarcopenia is characterized by a generalized progressive loss of skeletal muscle mass, strength, and physical performance. This systematic review primarily evaluated the effects of sarcopenia on postoperative functional recovery and mortality in patients undergoing orthopaedic surgery, and secondarily assessed the methods used to diagnose and define sarcopenia in the orthopaedic literature.
A systematic search was conducted in MEDLINE, EMBASE, and Google Scholar databases according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Studies involving sarcopenic patients who underwent defined orthopaedic surgery and recorded postoperative outcomes were included. The quality of the criteria by which a diagnosis of sarcopenia was made was evaluated. The quality of the publication was assessed using Newcastle-Ottawa Scale.
A total of 365 studies were identified and screened, 26 full-texts were reviewed, and 19 studies were included in the review. A total of 3,009 patients were included, of whom 2,146 (71%) were female and 863 (29%) were male. The mean age of the patients was 75.1 years (SD 7.1). Five studies included patients who underwent spinal surgery, 13 included hip or knee surgery, and one involved patients who underwent fixation of a distal radial fixation. The mean follow-up was 1.9 years (SD 1.9; 5 days to 5.6 years). There was wide heterogeneity in the measurement tools which were used and the parameters for the diagnosis of sarcopenia in the studies. Sarcopenia was associated with at least one deleterious effect on surgical outcomes in all 19 studies. The postoperative rate of mortality was reported in 11 studies (57.9%) and sarcopenia was associated with poorer survival in 73% (8/11) of these. The outcome was most commonly assessed using the Barthel Index (4/19), and sarcopenic patients recorded lower scores in 75% (3/4) of these. Sarcopenia was defined using the gold-standard three parameters (muscle strength, muscle quantity or quality, and muscle function) in four studies (21%), using two parameters in another four (21%) and one in the remaining 11 (58%). The methodological quality of the studies was moderate to high.
There is much heterogeneity in the reporting of the parameters which are used for the diagnosis of sarcopenia, and evaluating the outcome of orthopaedic surgery in sarcopenic patients. However, what data exist suggest that sarcopenia impairs recovery and increases postoperative mortality, especially in patients undergoing emergency surgery. Further research is required to develop processes that allow the accurate diagnosis of sarcopenia in orthopaedics, which may facilitate targeted pre- and postoperative interventions that would improve outcomes. Cite this article: 2022;104-B(3):321-330.
肌少症的特征是骨骼肌质量、力量和身体机能的全面进行性丧失。本系统评价主要评估了肌少症对接受骨科手术患者术后功能恢复和死亡率的影响,其次评估了骨科文献中用于诊断和定义肌少症的方法。
根据系统评价和荟萃分析的首选报告项目(PRISMA)指南,在 MEDLINE、EMBASE 和 Google Scholar 数据库中进行了系统检索。纳入了接受明确骨科手术并记录术后结果的肌少症患者的研究。评估了用于诊断肌少症的标准的质量。使用纽卡斯尔-渥太华量表评估出版物的质量。
共确定了 365 项研究并进行了筛选,对 26 篇全文进行了审查,共有 19 项研究纳入了本综述。共纳入了 3009 名患者,其中 2146 名(71%)为女性,863 名(29%)为男性。患者的平均年龄为 75.1 岁(SD 7.1)。5 项研究纳入了接受脊柱手术的患者,13 项研究纳入了髋部或膝关节手术患者,1 项研究纳入了桡骨远端固定术患者。平均随访时间为 1.9 年(SD 1.9;5 天至 5.6 年)。研究中使用的测量工具和诊断肌少症的参数存在很大的异质性。在所有 19 项研究中,肌少症至少对手术结果产生了一种有害影响。11 项研究(57.9%)报告了术后死亡率,其中 73%(8/11)与较差的生存率相关。结局最常使用 Barthel 指数(4/19)评估,这些研究中肌少症患者的评分均下降了 75%(3/4)。在四项研究(21%)中使用了肌肉力量、肌肉数量或质量和肌肉功能的金标准三个参数来定义肌少症,在另外四项研究(21%)中使用了两个参数,在其余 11 项研究(58%)中使用了一个参数。研究的方法学质量为中等到较高。
在用于诊断肌少症的参数报告方面存在很大的异质性,并且评估肌少症患者的骨科手术结局。然而,现有的数据表明,肌少症会损害恢复并增加术后死亡率,尤其是在接受急诊手术的患者中。需要进一步研究来开发允许在骨科中准确诊断肌少症的流程,这可能有助于促进有针对性的术前和术后干预措施,从而改善结局。引用本文:2022;104-B(3):321-330。